Cargando…
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
BACKGROUND: Treatment for patients with breast cancer (BC) is guided by human epidermal growth factor receptor 2 (HER2) status. The patient’s HER2 status is assessed using US Food and Drug Administration-approved in vitro diagnostic (IVD) immunohistochemical (IHC) tests and laboratory-developed IVD...
Autores principales: | Vyberg, Mogens, Nielsen, Søren, Røge, Rasmus, Sheppard, Beth, Ranger-Moore, Jim, Walk, Eric, Gartemann, Juliane, Rohr, Ulrich-Peter, Teichgräber, Volker |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553016/ https://www.ncbi.nlm.nih.gov/pubmed/26318869 http://dx.doi.org/10.1186/s12913-015-1018-6 |
Ejemplares similares
-
Lessons Learned, Challenges Taken, and Actions Made for “Precision” Immunohistochemistry. Analysis and Perspectives From the NordiQC Proficiency Testing Program
por: Nielsen, Søren, et al.
Publicado: (2023) -
Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
por: Vyberg, Mogens, et al.
Publicado: (2015) -
Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas
por: Nielsen, Sofie L., et al.
Publicado: (2017) -
Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene
por: Thomsen, Christian, et al.
Publicado: (2020) -
Modified Early Warning Scores: inaccurate summation or inaccurate assignment of score?
por: Edwards, M, et al.
Publicado: (2010)